Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

23.81

-0.07(-0.29%)

Updated at November 07 03:00PM

Currency In CNY

Valuation

Market Cap3.19B
Enterprise Value3.06B
P/E Ratio24.31
PEG Ratio1.76
Price/Sales Ratio6.65
Price/Book Ratio2.46
Enterprise/Revenue6.33
Enterprise/EBITDA20.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.27
Operating Margin0.28

Management Effectiveness

Return On Assets0.09
Return On Equity0.1

Income Statement

Revenue555.59M
Revenue/Share3.59
Gross Profit242.32M
EBITDA196.9M
Net Income124.21M
Diluted EPS0.74

Balance Sheet

Total Cash292.69M
Total Cash/Share1.74
Total Debt87.44M
Total Debt/Equity0.05
Current Ratio4.76
Book Value Per Share9.76

Price History

52-Week Change13.81
52-Week High31.13
52-Week Low16.93
Moving Average 50 Days25.5
Moving Average 200 Days25.28

Statistics

Average Volume3.65M
Shares Outstanding168.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.84
Payout Ratio0.01
Last Split Factor7:5
Last Split DateJuly 18, 2023